Company Overview and News

0
Reliance Infrastructure Limited - Option to submit Standalone/Consolidated Financial Results

2018-06-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
RInfra gets MERC approval for deal with Adani Transmission

2018-06-28 livemint
New Delhi: Reliance Infrastructure (RInfra) on Thursday said the Maharashtra Electricity Regulatory Commission (MERC) has approved the 100% stake sale in its integrated Mumbai power business to Adani Transmission Ltd (ATL) for an estimated value of Rs18,800 crore.
500390 RELINFRA 532662 RELEY RIFS 539254 HTMEDIA RIFA RELFF ADANITRANS

0
MERC approves sale of RInfra#39;s Mumbai power biz to Adani Transmission

2018-06-28 moneycontrol
Reliance Infrastructure today said the Maharashtra Electricity Regulatory Commission (MERC) has approved the 100 percent stake sale in its integrated Mumbai power business to Adani Transmission Ltd (ATL) for an estimated value of Rs 18,800 crore. "Following the commission's nod, the transaction is expected to be closed in July 2018. The MERC had concluded its hearing into the matter and reserved its order on June 14, 2018," it said in a BSE filing.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

0
Reliance Infrastructure Limited - Press Release

2018-06-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
Steady cash flows, low risk make power transmission segment a safe bet

2018-06-24 livemint
Mumbai: With over 22,000 megawatts (MW) of installed power capacity starved of coal and natural gas supplies, power generation is no longer the hot investment target it used to be. What is taking its place—where everybody now wants a piece of the action—is last-mile delivery of power: transmission.
GKO RELEY TATAPOWER RIFS 539254 RELFF 500390 RELINFRA TPCL RIFA 522287 KALPATPOWR 500400 ADANITRANS

17
MFs offloaded shares in PowerGrid, InterGlobe Aviation in May

2018-06-20 thehindubusinessline
Suresh P Iyengar The mutual fund industry has offloaded 22 per cent of Power Grid Corporation shares worth ₹1,905 crore in May, as prospects of the company looked bleak with no major new power project being launched and a sharp decline in power generation.
RIFS 532617 HCTHY TTQQY TATACHEM 500390 PIDILITIND PDLTY 532281 HDFCBANK 500770 500331 INDIGO RELEY IBN RELFF JETAIRWAYS 535322 REPCOHOME 539448 RELINFRA ICICIBANK HDB 532174 500180 HCLTECH RIFA 534809 PCJEWELLER

12
93% land acquired for Mumbai-Nagpur Expressway: Devendra Fadnavis

2018-06-18 freepressjournal.in
Mumbai: Maharashtra has completed 93 per cent of land acquisition for the 700-km Mumbai- Nagpur Expressway, according to chief minister Devendra Fadnavis. “In less than 12 months, the state has acquired 93 per cent of the land needed to build the Mumbai-Nagpur 700-km super communication highway with 24 nodes or interchanges that will be developed as smart cities along its path,” American brokerage Morgan Stanley said in a note quoting the chief minister as saying.
RELEY RIFS MS.PRE MS.PRF RELFF MS.PRG MS.PRA 500390 RELINFRA MS.PRI MS.PRK RIFA MS

0
MMRDA evaluating bids from IL&FS, Reliance Infrastructure for Mumbai monorail

2018-06-18 freepressjournal.in
Mumbai: The Mumbai Metropolitan Region Development Authority (MMRDA) is evaluating bids submitted by IL&FS and Anil Ambani’s Reliance Infrastructure for handling operations and maintenance of the country’s first monorail.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
The Maharashtra Electricity Regulatory Commission reserves order on RInfra-Adani deal

2018-06-14 moneycontrol
The Maharashtra Electricity Regulatory Commission (MERC) today concluded its hearing on the proposed sale of Reliance Infrastructure's Mumbai power distribution business to Adani Transmission for an estimated Rs 18,800 crore.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

0
Merc reserves order on Reliance Infra-Adani Transmission deal

2018-06-14 freepressjournal.in
Mumbai: The Maharashtra Electricity Regulatory Commission (Merc) today concluded its hearing on the proposed sale of Reliance Infrastructure’s Mumbai power distribution business to Adani Transmission for an estimated Rs 18,800 crore.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

0
Mumbai: MMRDA begins soil testing for Metro 4 corridor construction

2018-06-05 freepressjournal.in
Mumbai: The Mumbai Metropolitan Region Development Authority (MMRDA) began construction on the metro corridor connecting Wadala-Ghatkopar-Thane-Kasarvadavali on Monday with soil testing work at the area near Bhakti Park at Wadala and planning for traffic diversion along the route. This Metro 4 corridor will be constructed simultaneously in five packages after contractors were appointed in March this year.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
13 lowest bidders named for Samruddhi Mahamarg E-way

2018-06-01 freepressjournal.in
Maharashtra State Road Development Corporation (MSRDC) Authorities’ announced 13 lowest bidders (L-1) out of 18 eligible financial bidders to construct 13 packages of the 700-km Nagpur-Mumbai Maharashtra Samruddhi Mahamarg (MSM) Expressway.
500390 RELINFRA 539150 RELEY RIFS RIFA RELFF PNCINFRA

0
Reliance Infrastructure Limited - Updates

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
Reliance Infrastructure Limited - Committee Meeting Updates

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
Reliance Infrastructure Limited - Credit Rating

2018-05-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

Silicon Investor Message Boards

This table lists all message boards related to LSE:RIFS / RELIANCE INFRASTRUCTURE LTD on message board site Silicon Investor.

Porkbelly futures u0026 political ramifications of Pork Tarrifs